Kevin T. Conroy - Feb 24, 2023 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
President and CEO, Director
Signature
/s/ Kevin T. Conroy by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Feb 24, 2023
Transactions value $
$0
Form type
4
Date filed
2/28/2023, 04:29 PM
Previous filing
Feb 23, 2023
Next filing
Mar 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EXAS Common Stock 1.2M Feb 24, 2023 Direct F1
holding EXAS Common Stock 27.1K Feb 24, 2023 Held in 401(k) Plan
holding EXAS Common Stock 21.7K Feb 24, 2023 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21.7K Feb 24, 2023 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21.7K Feb 24, 2023 Held in Grantor Retained Annuity Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Award $0 +72.6K $0.00 72.6K Feb 24, 2023 Common Stock 72.6K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In addition to the shares of Common Stock reported on this Form 4, which total 1,287,544 shares, Mr. Conroy also holds, in the aggregate, an additional 792,505 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 These restricted stock units vest in four equal annual installments beginning on February 29, 2024.